Skip to main content

Table 3 Median CVI (%) of healthy and chronic diseases in the Ricos C. et al. study and mean CVI (%) of HIV-uninfected and infected men in our study

From: Long-term intra- and inter-individual biological variation of serum lipid of HIV-infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study (MACS)

Median CVI (%) of Ricos C. et al. [28]

HDL-C

LDL-C

T. Cholesterol

Triglycerides

Healthy subjects

7.1

8.3

6.0

20.9

Chronic liver Disease

-

-

5.2

-

Chronic renal failure

9.5

-

-

15.4

Coronary heart disease

-

9.5

-

-

Diabetes Mellites Type I

7.7

-

7.2

20.0

Diabetes Mellites Type II

-

-

-

-

Hypertension

8.7

-

7.0

21.8

Impaired renal function

-

-

-

-

Lipid disorders

7.1

7.8

5.0

17.8

Mild Hypercholesterolemia

-

6.6

4.7

19.6

Our study

HIV-uninfected on CLDs

(1 year)

13.4

15.8

10.6

40.7

(17 year)

15.9

24.9

16.1

43.8

HIV-uninfected not on CLDs

(1 year)

14.1

15.8

10.2

33.6

(17 year)

13.8

15.8

11.0

36.6

HIV-infected on CLDs

(1 year)

16.0

21.4

13.6

60.4

(17 year)

19.5

27.3

18.6

69.0

HIV-infected not on CLDs (1 year)

(17 year)

16.7

16.2

10.0

40.0

19.6

20.8

13.4

47.0